Loading Events

« All Events

  • This event has passed.

Live interview: Advances in glucagon with Locemia Solutions

August 13, 2015 @ 1:00 pm - 2:00 pm

1pm PT, 4pm ET, 8pm GMT

What time is this where you are?

Join us HERE at the time and date of the event

Locemia Solutions is a Canadian-based pharmaceutical development company, which sole focus is on innovating the rescue treatment of severe hypoglycemia. The team at Locemia is working on providing people with diabetes and those that touch their lives, with a simple, needle-free glucagon rescue product for the treatment of severe hypoglycemia, which would be easy to teach, easy to carry and easy to use – helping to expand the number of people who feel confident in dealing with the unpredictability of hypoglycemia, and providing peace of mind for people who use insulin every day. Locemia’s passion and promise – driven by its members personal involvement and investment in the diabetes community – is to fill an unmet need through innovation, awareness and empowerment—rooted in needle-free simplicity,  for everyone to be able to help anyone—quickly and easily— deal with severe low blood sugar.

 

Dr. Claude Piché
Co-Creator and CEO
Claude is leading the development of our solution. He has over 25 years of experience in developing and commercializing pharmaceuticals, vaccines, and diagnostics, including more than 12 years where he focused on diabetes therapeutics and hypoglycemia-related technologies. He has worked at large companies such as Merck, as well as start-up biopharmaceutical companies where he had roles in research, regulatory affairs, marketing, and operations.
Robert Oringer
Co-Creator and Chairman
Robert is passionate about reducing the burdens of dealing with diabetes. He has a long history of spreading the “be prepared” message as it relates to hypoglycemia and is a strong advocate for simplifying hypoglycemia rescue. He has over 25 years of experience as an entrepreneur, investor, and board leader in the diabetes field. Robert’s first diabetes company, CanAm Care, was built in the 1990s and created Dex4®, the leading brand of nonprescription hypoglycemia treatment products. Robert’s focus on bringing innovative ideas to diabetes stems from the experience of raising his two sons, both of whom have type 1 diabetes.

Details

Date:
August 13, 2015
Time:
1:00 pm - 2:00 pm

Below Content Ad